Enter Note Done
Go to previous page in this tab
Event
  • Scientific Session
  • Bookmark Icon
  • Raising the Bar: Modern Intake Assessments and the New Regulatory Landscape for Food Ingredient Safety
  • Schedule
    Notes
  • Stars at Night Ballroom B4‚ Convention Center
    Set Timezone


Chair: Brinda Mahadevan, Brincor Associates LLC
Co-Chair: Matthew Linman, Trinity Consultants

Primary Endorser: Exposure Specialty Section


Endorser(s): Food Safety Specialty Section


Endorser(s): Regulatory and Safety Evaluation Specialty Section


Dietary intake assessment is a foundational yet increasingly scrutinized component of food ingredient safety evaluations. In GRAS determinations, food additive petitions, and related regulatory submissions, the quality, transparency, and interpretation of dietary exposure data often determine whether a safety conclusion is accepted, challenged, or returned for further justification. Despite its central role in making safety decisions, the field lacks a unified framework for how intake data should be generated, validated, and applied — and expectations continue to evolve across industry, academia, and regulatory agencies. This session brings together perspectives from consulting, academia, industry, and FDA to provide an integrated examination of how dietary intake assessment is practiced and interpreted across the full arc of a food ingredient safety evaluation. The session opens with an overview of intake assessment fundamentals, including deterministic versus probabilistic approaches and the selection and validation of consumption data sources such as NHANES/WWEIA. Building on this foundation, the next presentation examines how exposure estimates are bridged to toxicological endpoints to support robust safety determinations, including considerations for dose response interpretation, margin of safety calculations, and cumulative exposure. An industry perspective then addresses the practical challenges of characterizing intake for high risk and high exposure populations — including infants, children, and high frequency consumers — and the implications of cumulative exposure across diverse product portfolios. The final presentation offers an FDA perspective on how the agency evaluates intake assumptions, data sufficiency, uncertainty, and fitness for purpose in the context of recent actions and evolving guidance. Together, these presentations aim to clarify when available intake data are adequate, where methodological refinement meaningfully improves safety conclusions, and how scientists across sectors can align dietary exposure assessment approaches with current regulatory expectations without unnecessary conservatism or complexity. Attendees will gain practical insights into current best practices for data selection and interpretation, awareness of common methodological pitfalls that can weaken regulatory submissions, and actionable strategies for strengthening the scientific defensibility of intake assessments in an evolving regulatory landscape. The session will conclude with a moderated panel discussion addressing key challenges in dietary intake assessment, including harmonization of methodological approaches across regulatory contexts, strategies for addressing data gaps in under-studied and vulnerable populations, and opportunities for cross-sector collaboration to advance best practices in exposure science.

Session and Activity Type
Presentations